脐带间充质干细胞外泌体LncRNA H19修复软骨损伤的机制  

Mechanism underlying exosomal lncRNA H19 derived from umbilical cord mesenchymal stem cells promotes cartilage injury repair

作　　者：王宪峰 王锟[2] 孙晗[2] 孙晓亮[2] 言力韬 Wang Xianfeng;Wang Kun;Sun Han;Sun Xiaoliang;Yan Litao(Department of Sports Medicine,Beijing Jishuitan Hospital Guizhou Hospital,Guiyang 550000,Guizhou Province,China;Department of Articular Orthopedics,Third Affiliated Hospital of Soochow University,Changzhou 213000,Jiangsu Province,China)

机构地区：[1]北京积水潭医院贵州医院运动医学科,贵州省贵阳市550000 [2]苏州大学附属第三医院骨关节科,江苏省常州市213000

出　　处：《中国组织工程研究》2024年第1期20-25,共6页Chinese Journal of Tissue Engineering Research

基　　金：国家自然科学基金青年项目(82202679),项目负责人:言力韬;江苏省高校自然科学研究面上项目(22KJB320008),项目负责人:言力韬;常州市应用基础研究计划项目(CJ20220109),项目负责人:言力韬;常州市应用基础研究计划项目(CJ20220070),项目负责人:王锟;常州市应用基础研究计划项目(CJ20220103),项目负责人:孙晗。

摘　　要：背景:脐带间充质干细胞已被证明对软骨损伤有治疗作用,外泌体是脐带间充质干细胞在体内发挥治疗作用的主要载体。课题组前期发现LncRNA H19是介导脐带间充质干细胞外泌体调控软骨细胞活性的重要活性分子,LncRNA H19可以吸附miR-29b-3p从而促进软骨细胞的增殖再生,但是其下游机制仍未清楚。目的:从外泌体和LncRNAs角度揭示脐带间充质干细胞治疗软骨损伤的具体机制,为软骨损伤的治疗提供新的靶点。方法:构建稳定过表达LncRNA H19的脐带间充质干细胞,采用超速离心提取外泌体(H19-Exos);采用透射电镜、纳米颗粒跟踪分析、Western blot和外泌体摄取实验鉴定外泌体;通过Western blot、qPCR和双荧光素酶报告基因系统检测miR-29b-3p过表达和沉默对TGF-β1/Smad3通路的影响;通过特异性TGF-β1/Smad3抑制剂在体内外反向验证H19-Exos对软骨再生的生物学作用。结果与结论:①H19-Exos在电镜下为典型的杯状,粒径在130 nm左右,均表达CD63、CD81和TSG1010特性蛋白;②过表达miR-29b-3p可以同时下调TGF-β1、Smad3的mRNA和蛋白水平,而沉默miR-29b-3p后,TGF-β1、Smad3的mRNA和蛋白水平上调;③双荧光素酶报告基因系统检测发现miR-29b-3p对下游靶基因TGF-β1和Smad3活性影响有显著差异;④膝关节腔内注射Ⅱ型胶原酶成功建立大鼠骨关节炎模型,H19-Exos可显著促进软骨再生,且特异性TGF-β1/Smad3抑制剂SB-431542在体内外均可阻断H19-Exos对软骨再生的生物学作用;⑤该研究系统论证了高表达LncRNA H19脐带间充质干细胞来源外泌体对软骨再生的促进作用,具体机制为LncRNA H19通过靶向miR-29b-3p/TGF-β1/Smad3通路促进软骨再生。BACKGROUND:Umbilical cord mesenchymal stem cells(UMSCs)have been proven to have therapeutic effects on cartilage injury,and exosomes are the main carriers for UMSCs to exert therapeutic effects in vivo.Our research group previously found that lncRNA H19 is an important active molecule that mediates the activity of UMSCs-derived exosomes regulating chondrocytes.LncRNA H19 could adsorb miR-29b-3p to promote the proliferation and regeneration of chondrocytes,but its downstream mechanism is still unclear.OBJECTIVE:To reveal the specific mechanism of UMSCs in the treatment of cartilage injury from the perspective of exosomes and lncRNAs,so as to provide a new target for the treatment of cartilage injury.METHODS:UMSCs stably overexpressing lncRNA H19 were constructed.H19-Exos were extracted by ultra-centrifugation.The exosomes were identified by transmission electron microscopy,Nanosight,western blot assay and exosome uptake assay.The effect of miR-29b-3p overexpression and silencing on the TGF-β1/Smad3 pathway was detected by western blot assay,qPCR and dual luciferase reporter gene system.The biological effect of H19-Exos on cartilage regeneration was verified by the specific TGF-β1/Smad3 inhibitor in vitro and in vivo.RESULTS AND CONCLUSION:(1)H19-Exos showed a typical cup shape under an electron microscope,and the particle size was approximately 130 nm.H19-Exos expressed CD63,CD81 and TSG1010.(2)Overexpression of miR-29b-3p could down-regulate the mRNA and protein levels of TGF-β1 and Smad3,while silencing miR-29b-3p could up-regulate the mRNA and protein levels of TGF-β1/Smad3.(3)Dual-luciferase reporter gene system showed that miR-29b-3p had significant differences in the activities of downstream target genes TGF-β1 and Smad3.(4)The osteoarthritis models of rats were successfully established by injection of type II collagenase into the knee joint.H19-Exos significantly promoted cartilage regeneration.The specific TGF-β1/Smad3 inhibitor SB-431542 could block the biological effect of H19-Exos on cartilage reg

关 键 词：骨性关节炎 间充质干细胞 外泌体 长链非编码RNA 

分 类 号：R459.9[医药卫生—治疗学] R318[医药卫生—临床医学] R684